Exponent's Neurelis Promotes Epilepsy Awareness at Sofie's Journey Expo 2025

Neurelis Champions Epilepsy Awareness at Sofie's Journey Expo

Neurelis, Inc., recognized for its pioneering diazepam nasal spray, VALTOCO®, actively engages in epilepsy education and support by participating in the 13th Annual Sofie's Journey Epilepsy Awareness Day & Education Expo at Disneyland. Scheduled for November 10-11, 2025, this significant event coincides with National Epilepsy Awareness Month, focusing on enhancing understanding and resources for individuals living with epilepsy, their caregivers, and healthcare providers. Neurelis is not only a participant but also a contributor to the event's educational agenda, emphasizing its commitment to the epilepsy community.

Among the highlights of Neurelis's participation is a presentation by Ambassador Lowell, an adult with epilepsy, who will share his personal journey with VALTOCO. Scheduled for November 11 from 11:00 to 11:30 AM in the Expo Center, Lowell's session aims to provide insights into living with epilepsy and the role that VALTOCO plays in managing frequent seizures. Following his presentation, a Q&A session will allow attendees to engage directly, fostering a supportive environment for discussion. Additionally, Ambassador Esteban will address families during a dinner event on November 10, recounting his experiences with surgery and medication adjustments. His testimony underscores how VALTOCO has empowered him, helping him regain independence and a sense of normalcy in his life.

Neurelis's Founder and CEO, Craig Chambliss, reaffirms the company's dedication to supporting those affected by epilepsy, highlighting the importance of community-driven efforts such as this expo. The collaboration with the Epilepsy Alliance of America enhances the event's mission, as both organizations work to raise awareness about seizures and provide necessary resources to those in need. By sharing impactful stories and engaging directly with the epilepsy community, Neurelis aims to create a lasting impression that resonates beyond the expo, fostering a sense of hope and empowerment among individuals with epilepsy and their families.

In addition to its presentations, Neurelis seeks to deepen relationships with healthcare practitioners attending the expo. By facilitating dialogue around innovative treatments like VALTOCO, the company aims to encourage informed discussions about seizure management and patient care. The expo serves as a platform for Neurelis to connect with both patients and healthcare professionals, reinforcing its commitment to improving the quality of life for those living with epilepsy.

As the company prepares for this important event, it remains focused on its mission to provide valuable insights and support, ensuring that individuals impacted by epilepsy feel understood and empowered in their journey.